Your browser doesn't support javascript.
loading
[Impact of the Chilean Explicit Guaranties Health System (GES) on breast cancer treatment]. / Resultados del tratamiento del cáncer de mama, Programa Nacional de Cáncer del Adulto.
Del Castillo Sm, César; Cabrera C, M Elena; Derio P, Lea; Gaete V, Fancy; Cavada Ch, Gabriel.
Afiliação
  • Del Castillo Sm C; Servicio de Oncología, Hospital San Borja Arriarán, Santiago, Chile.
  • Cabrera C ME; Ministerio de Salud, Santiago, Chile.
  • Derio P L; Departamento de Cáncer, Ministerio de Salud, Santiago, Chile.
  • Gaete V F; Servicio Anatomía Patológica, Hospital Luis Tisné, Santiago, Chile.
  • Cavada Ch G; Escuela de Salud Pública, Santiago, Chile.
Rev Med Chil ; 145(12): 1507-1513, 2017 Dec.
Article em Es | MEDLINE | ID: mdl-29652946
Background Breast cancer is the most common malignant tumor in women in the world. In 2005, it was incorporated to the Explicit Guaranties Health System (GES) in Chile. Aim To describe the demographic and clinical characteristics of breast cancer patients and to determine the effect of incorporating these women to GES. Material and Methods Medical records of 5,119 women with breast cancer aged 59 ± 14 years, attended at six public hospitals between 2000 and 2010 were reviewed. Median follow up was 87 months (range 1-182). Mortality was assessed using death certificates obtained at the National Identification Registry. Results Sixty six percent of women were in stage I-II, 29% in stage III and 5% in stage IV. Surgery was performed in 4023/5119 cases (79%), adyuvant radiotherapy in 3627/4517 cases (80%), chemotherapy in 3,204/3,424 cases (94%) and hormone therapy in 1,695/2,375 cases (71%). Between 2000 and 2010, there was a significant increase in the proportion of cases in stage I, from 8% to 25%, (p < 0.01). Overall survival (OS) increased 1% per year, since the beginning of GES system (p = 0.024). Five year OS was 75.1%. The figures for Stage I, II, III and IV were 93, 84, 62 and 27% respectively (p < 0.01). Patients without lymph node involvement and who were not triple negative, had a significantly better OS. Conclusions There was a significant increase in stage I cases, and a 1% per year OS improvement after GES system started, compared with the previous period.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Garantia da Qualidade dos Cuidados de Saúde / Neoplasias da Mama / Carcinoma / Programas Nacionais de Saúde Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Chile Idioma: Es Revista: Rev Med Chil Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Chile País de publicação: Chile

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Garantia da Qualidade dos Cuidados de Saúde / Neoplasias da Mama / Carcinoma / Programas Nacionais de Saúde Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Chile Idioma: Es Revista: Rev Med Chil Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Chile País de publicação: Chile